These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 8862227

  • 21. Endothelin and endothelin antagonists in hypertension.
    Schiffrin EL.
    J Hypertens; 1998 Dec; 16(12 Pt 2):1891-5. PubMed ID: 9886874
    [Abstract] [Full Text] [Related]

  • 22. Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
    Li JS, Sventek P, Schiffrin EL.
    J Hypertens; 1996 Nov; 14(11):1331-9. PubMed ID: 8934362
    [Abstract] [Full Text] [Related]

  • 23. Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension.
    Matsumura Y, Kuro T, Kobayashi Y, Konishi F, Takaoka M, Wessale JL, Opgenorth TJ, Gariepy CE, Yanagisawa M.
    Circulation; 2000 Nov 28; 102(22):2765-73. PubMed ID: 11094045
    [Abstract] [Full Text] [Related]

  • 24. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats.
    Intengan HD, He G, Schiffrin EL.
    Hypertension; 1998 Oct 28; 32(4):770-7. PubMed ID: 9774378
    [Abstract] [Full Text] [Related]

  • 25. Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats.
    Li JS, Knafo L, Turgeon A, Garcia R, Schiffrin EL.
    Am J Physiol; 1996 Jul 28; 271(1 Pt 2):H88-93. PubMed ID: 8760162
    [Abstract] [Full Text] [Related]

  • 26. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD, Pollock DM, Clarke N, Fuchs LC.
    Am J Physiol; 1998 Jun 28; 274(6):R1613-8. PubMed ID: 9608015
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
    Yu M, Gopalakrishnan V, Wilson TW, McNeill JR.
    Am J Physiol Heart Circ Physiol; 2001 Dec 28; 281(6):H2511-7. PubMed ID: 11709418
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats.
    Matsumura Y, Taira S, Kitano R, Hashimoto N, Kuro T.
    Biol Pharm Bull; 1999 Aug 28; 22(8):858-62. PubMed ID: 10480326
    [Abstract] [Full Text] [Related]

  • 31. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Hashimoto N, Takaoka M, Morimoto S.
    Life Sci; 1996 Aug 28; 58(1):PL1-7. PubMed ID: 8628104
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S.
    Jpn J Pharmacol; 1996 Apr 28; 70(4):313-9. PubMed ID: 8774759
    [Abstract] [Full Text] [Related]

  • 35. Endothelin receptor A blockade reduces proteinuria and vascular hypertrophy in spontaneously hypertensive rats on high-salt diet in a blood-pressure-independent manner.
    Trenkner J, Priem F, Bauer C, Neumayer HH, Raschak M, Hocher B.
    Clin Sci (Lond); 2002 Aug 28; 103 Suppl 48():385S-388S. PubMed ID: 12193128
    [Abstract] [Full Text] [Related]

  • 36. Blood pressure and small arteries in DOCA-salt-treated genetically AVP-deficient rats: role of endothelin.
    Intengan HD, Park JB, Schiffrin EL.
    Hypertension; 1999 Oct 28; 34(4 Pt 2):907-13. PubMed ID: 10523383
    [Abstract] [Full Text] [Related]

  • 37. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism.
    Sharifi AM, Schiffrin EL.
    J Hypertens; 1997 Dec 28; 15(12 Pt 1):1441-8. PubMed ID: 9431850
    [Abstract] [Full Text] [Related]

  • 38. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V, Wangensteen R, Sainz J, Duarte J, O'Valle F, Osuna A, Vargas F.
    Clin Sci (Lond); 2004 Mar 28; 106(3):251-9. PubMed ID: 14521506
    [Abstract] [Full Text] [Related]

  • 39. DOCA-salt induced malignant hypertension in spontaneously hypertensive rats.
    Sesoko S, Pegram BL, Willis GW, Frohlich ED.
    J Hypertens; 1984 Feb 28; 2(1):49-54. PubMed ID: 6530537
    [Abstract] [Full Text] [Related]

  • 40. Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension.
    Trensz F, Bortolamiol C, Kramberg M, Wanner D, Hadana H, Rey M, Strasser DS, Delahaye S, Hess P, Vezzali E, Mentzel U, Ménard J, Clozel M, Iglarz M.
    J Pharmacol Exp Ther; 2019 Mar 28; 368(3):462-473. PubMed ID: 30622171
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.